Literature DB >> 20963328

Prevalence and antimicrobial susceptibility of respiratory pathogens in patients with cystic fibrosis.

Vilma Almeida Paixão1, Tânia Fraga Barros, Clélia Maria C Mota, Tamy Fagundes Moreira, Maria Angélica Santana, Joice Neves Reis.   

Abstract

Respiratory infection is very common in patients suffering from cystic fibrosis (CF). However, the antimicrobial resistance rate of isolates from CF patients is not often documented. In this study, 279 respiratory specimens of 146 patients were prospectively collected from July to December 2006. Microbiological cultures and antimicrobial susceptibility tests of the most frequently isolated bacteria were performed. Sputum and oropharyngeal swabs were processed for culture. During the study period, 50% of the patients harbored Staphylococcus aureus, 35% Pseudomonas aeruginosa, 4.7% Haemophilus influenzae. Methicillin resistant S. aureus (MRSA) were detected in 8 (6%) patients; ESBL and MBL-producing P. aeruginosa were not identified in these patients. The detection of MRSA in CF patients confirms that antimicrobial resistance patterns should be always kept under surveillance. Moreover, hygiene regulations in CF clinics should prevent a further spread of resistant bacterial strains.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20963328

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  7 in total

1.  Identification and characterization of bacteria isolated from patients with cystic fibrosis in Jordan.

Authors:  Nid'a Alshraiedeh; Farah Atawneh; Rasha Bani-Salameh; Rawan Alsharedeh; Yara Al Tall; Mohammad Alsaggar
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

2.  Phenotypic and Genetic Characterization of Carbapenemase and ESBLs Producing Gram-negative Bacteria (GNB) Isolated from Patients with Cystic Fibrosis (CF) in Tehran Hospitals.

Authors:  Parisa Vali; Fereshteh Shahcheraghi; Maryam Seyfipour; Maryam Alsadat Zamani; Mohammad Reza Allahyar; Mohammad Mehdi Feizabadi
Journal:  J Clin Diagn Res       Date:  2014-01-12

3.  Hypermutable Pseudomonas aeruginosa in Cystic fibrosis patients from two Brazilian cities.

Authors:  Larissa Lutz; Robson Souza Leão; Alex Guerra Ferreira; Dariane Castro Pereira; Caroline Raupp; Tyrone Pitt; Elizabeth Andrade Marques; Afonso Luis Barth
Journal:  J Clin Microbiol       Date:  2013-01-09       Impact factor: 5.948

4.  Aetiological agents for pulmonary exacerbations in children with cystic fibrosis: An observational study from a tertiary care centre in northern India.

Authors:  Balaji Arvind; Guruprasad R Medigeshi; Arti Kapil; Immaculata Xess; Urvashi Singh; Rakesh Lodha; Sushil Kumar Kabra
Journal:  Indian J Med Res       Date:  2020-01       Impact factor: 2.375

5.  Interspecific small molecule interactions between clinical isolates of Pseudomonas aeruginosa and Staphylococcus aureus from adult cystic fibrosis patients.

Authors:  Alexandre Fugère; David Lalonde Séguin; Gabriel Mitchell; Eric Déziel; Valérie Dekimpe; André M Cantin; Eric Frost; François Malouin
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

6.  Microbiology of the middle meatus compared to sputum in young patients with cystic fibrosis from Bahia - Brazil.

Authors:  Alessandro Tunes; Joice Neves Reis; Regina Terse; Maria Angélica Santana; Ana Lúcia Diniz; Tânia Fraga Barros; Ana Karina Souza Leal; Vilma Paixão; Maria Fernanda Rios Grassi
Journal:  Braz J Infect Dis       Date:  2013-11-22       Impact factor: 3.257

7.  Incidence and treatment of methicillin-resistant S. aureus infection in cystic fibrosis patients: a cohort study.

Authors:  Paloma Horejs Bittencourt; Carlos Sidney Silva Pimentel; Bianca Sampaio Bonfim; Paulo José Marostica; Edna Lúcia Souza
Journal:  Braz J Infect Dis       Date:  2016-10-15       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.